DOTA-LM3 TFA
DOTA-LM3 TFA is a somatostatin receptor antagonist peptide used in nuclear medicine research. Its 68Ga-labeled version is a promising PET imaging agent for SSTR-positive tumors, while the 177Lu-labeled analogue is studied for targeted radionuclide therapy, particularly in DOTATOC-negative metastases.
Product Specifications
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Molecular Weight
1664.18
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog